Contribution of Panton-Valentine leukocidin in community-associated methicillin-resistant Staphylococcus aureus pathogenesis.
Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) strains typically carry genes encoding Panton-Valentine leukocidin (PVL). We used wild-type parental and isogenic PVL-deletion (Delta pvl) strains of USA300 (LAC and SF8300) and USA400 (MW2) to test whether PVL alters global gene regulatory networks and contributes to pathogenesis of bacteremia, a hallmark feature of invasive staphylococcal disease. Microarray and proteomic analyses revealed that PVL does not alter gene or protein expression, thereby demonstrating that any contribution of PVL to CA-MRSA pathogenesis is not mediated through interference of global gene regulatory networks. Inasmuch as a direct role for PVL in CA-MRSA pathogenesis remains to be determined, we developed a rabbit bacteremia model of CA-MRSA infection to evaluate the effects of PVL. Following experimental infection of rabbits, an animal species whose granulocytes are more sensitive to the effects of PVL compared with the mouse, we found a contribution of PVL to pathogenesis over the time course of bacteremia. At 24 and 48 hours post infection, PVL appears to play a modest, but measurable role in pathogenesis during the early stages of bacteremic seeding of the kidney, the target organ from which bacteria were not cleared. However, the early survival advantage of this USA300 strain conferred by PVL was lost by 72 hours post infection. These data are consistent with the clinical presentation of rapid-onset, fulminant infection that has been associated with PVL-positive CA-MRSA strains. Taken together, our data indicate a modest and transient positive effect of PVL in the acute phase of bacteremia, thereby providing evidence that PVL contributes to CA-MRSA pathogenesis.
Diep
Binh An
BA
Division of Infectious Diseases, Department of Medicine, San Francisco General Hospital, University of California San Francisco, San Francisco, California, United States of America.
Palazzolo-Ballance
Amy M
AM
Tattevin
Pierre
P
Basuino
Li
L
Braughton
Kevin R
KR
Whitney
Adeline R
AR
Chen
Liang
L
Kreiswirth
Barry N
BN
Otto
Michael
M
DeLeo
Frank R
FR
Chambers
Henry F
HF
D000818:Animals; D016470:Bacteremia / Q000175:diagnosis / Q000378:metabolism; D001427:Bacterial Toxins / Q000378:metabolism*; D004195:Disease Models, Animal; D005098:Exotoxins / Q000378:metabolism*; D017353:Gene Deletion; D020869:Gene Expression Profiling; D015964:Gene Expression Regulation, Bacterial; D006098:Granulocytes / Q000166:cytology; D007956:Leukocidins / Q000378:metabolism*; D016106:Methicillin Resistance / Q000187:drug effects / Q000235:genetics*; D020411:Oligonucleotide Array Sequence Analysis; D040901:Proteomics / Q000379:methods; D011817:Rabbits; D020133:Reverse Transcriptase Polymerase Chain Reaction; D013211:Staphylococcus aureus / Q000378:metabolism* / Q000472:pathogenicity; D037521:Virulence Factors
D001427:Bacterial Toxins; D005098:Exotoxins; D007956:Leukocidins; C078284:Panton-Valentine leukocidin; D037521:Virulence Factors
Emerg Infect Dis. 2005 Apr;11(4):526-32
15829189
Cell Microbiol. 2007 May;9(5):1172-90
17217429
Lancet. 2005 Apr 2-8;365(9466):1256-8
15811459
J Infect Dis. 2006 Jun 1;193(11):1495-503
16652276
Pediatrics. 2005 Mar;115(3):642-8
15741366
J Infect Dis. 2008 Oct 15;198(8):1166-70
18729780
JAMA. 2007 Oct 17;298(15):1763-71
17940231
J Infect Dis. 2006 Dec 15;194(12):1761-70
17109350
Trends Microbiol. 2008 Aug;16(8):361-9
18585915
J Clin Microbiol. 2007 Aug;45(8):2554-63
17581935
J Bacteriol. 1998 May;180(10):2609-15
9573143
Infect Immun. 1994 Nov;62(11):4831-7
7927762
Stat Med. 1985 Jan-Mar;4(1):87-90
3992076
J Pathol Bacteriol. 1966 Apr;91(2):599-604
4224060
Emerg Infect Dis. 2003 Aug;9(8):978-84
12967497
N Engl J Med. 2006 Aug 17;355(7):666-74
16914702
Nat Med. 2007 Dec;13(12):1405-6
18064027
Infect Immun. 2003 Jul;71(7):3724-9
12819053
Zentralbl Bakteriol. 1999 Apr;289(2):185-201
10360319
N Engl J Med. 2005 Apr 7;352(14):1485-7
15814886
Science. 2007 Feb 23;315(5815):1130-3
17234914
Arch Intern Med. 2007 May 28;167(10):1026-33
17533205
Proc Natl Acad Sci U S A. 2008 Jan 29;105(4):1327-32
18216255
J Infect Dis. 1995 Mar;171(3):607-13
7533198
Ann Intern Med. 2006 Mar 7;144(5):309-17
16520471
JAMA. 2003 Dec 10;290(22):2976-84
14665659
J Infect Dis. 2008 Jun 1;197(11):1523-30
18700257
J Exp Med. 2008 Feb 18;205(2):287-94
18268041
Lancet. 2006 Mar 4;367(9512):731-9
16517273
Nat Med. 2004 Aug;10(8):842-8
15247912
Microbiology (Reading). 2007 May;153(Pt 5):1604-1608
17464075
J Immunol. 2008 Jan 1;180(1):500-9
18097052